BREAKING
Earnings Summary: Zymeworks (ZYME) Q4 FY25 net loss widens 1 day ago Earnings Summary: A snapshot of Smith+Nephew’s (SNN) Q4 2025 report 1 day ago Earnings Summary: Norwegian Cruise Line (NCLH) Q4 FY25 revenue rises 6% 1 day ago Earnings Summary: Highlights of Calumet’s (CLMT) Q4 2025 earnings report 4 days ago Zoom Communications Q4 2025 Earnings Results 5 days ago Agilent Q1 Revenue Rises 7%, Net Income Declines 5 days ago Synopsys Q1 2026 Earnings Results 5 days ago Key highlights from J.M. Smucker’s (SJM) Q3 2026 earnings results 5 days ago Hormel Foods (HRL) Q1 2026 Earnings: Key financials and quarterly highlights 5 days ago Key metrics from Lowe’s (LOW) Q4 2025 earnings results 6 days ago Earnings Summary: Zymeworks (ZYME) Q4 FY25 net loss widens 1 day ago Earnings Summary: A snapshot of Smith+Nephew’s (SNN) Q4 2025 report 1 day ago Earnings Summary: Norwegian Cruise Line (NCLH) Q4 FY25 revenue rises 6% 1 day ago Earnings Summary: Highlights of Calumet’s (CLMT) Q4 2025 earnings report 4 days ago Zoom Communications Q4 2025 Earnings Results 5 days ago Agilent Q1 Revenue Rises 7%, Net Income Declines 5 days ago Synopsys Q1 2026 Earnings Results 5 days ago Key highlights from J.M. Smucker’s (SJM) Q3 2026 earnings results 5 days ago Hormel Foods (HRL) Q1 2026 Earnings: Key financials and quarterly highlights 5 days ago Key metrics from Lowe’s (LOW) Q4 2025 earnings results 6 days ago
ADVERTISEMENT
AlphaGraphs

Infographic: Highlights of Aurora Cannabis (ACB) Q4 2021 earnings report

Aurora Cannabis, Inc. (NYSE: ACB) on Monday reported a net loss for the fourth quarter of 2021, continuing the recent trend. However, the bottom-line performance improved from the year-ago period. The Canada-based medical marijuana company’s loss from continuing operations was C$133.9 million in the June quarter, which marked a significant improvement from last year’s loss […]

$ACB September 27, 2021 1 min read
NYSE
$ACB · Earnings

Aurora Cannabis, Inc. (NYSE: ACB) on Monday reported a net loss for the fourth quarter of 2021, continuing the recent trend. However, the bottom-line performance improved from the year-ago period. The Canada-based medical marijuana company’s loss from continuing operations was C$133.9 million in the June quarter, which marked a significant improvement from last year’s loss […]

· September 27, 2021

Aurora Cannabis, Inc. (NYSE: ACB) on Monday reported a net loss for the fourth quarter of 2021, continuing the recent trend. However, the bottom-line performance improved from the year-ago period.

Aurora Cannabis Q4 2021 earnings infographic

The Canada-based medical marijuana company’s loss from continuing operations was C$133.9 million in the June quarter, which marked a significant improvement from last year’s loss of C$1.84 billion. Loss narrowed despite a 20% year-over-year decrease in revenues to C$54.8 million.


Read management/analysts’ comments on Aurora’s Q4 results


Shares of Aurora Cannabis dropped soon after the earnings release on Monday evening in the New York Stock Exchange, after closing the regular session down 7%.

ADVERTISEMENT

Prior Performance

ADVERTISEMENT